Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05825508 · ClinicalTrials.gov registry record

PedBot Ankle Rehablitation

A clinical trial of Cerebral Palsy, sponsored by Children's National Research Institute.

Active
Registry status
20
Enrollment target
1
Study location

NCT05825508: Active study of Cerebral Palsy, sponsored by Children's National Research Institute.

NCT05825508 is a study of Cerebral Palsy that is active but no longer recruiting, run by Children's National Research Institute. The registered enrollment target is 20 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05825508, a study of Cerebral Palsy, is active but no longer recruiting, sponsored by Children's National Research Institute.

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the study is to determine engagement with use and adherence to a home exercise program with our PedBotHome ankle rehabilitation device. We will place the device in the home for 90 days and consider the study a success if used for at least 30 minutes a day for at least 3 days a week during this period.

Primary Outcome

integer

Conditions Studied

Interventions

  • DEVICE ankle robot

Study Locations (1)

District of Columbia

  • Children's National Health System - Washington D.C.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-07-28
Est. Completion 2025-07-28

What the registry record for NCT05825508 still lists

NCT05825508 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which ankle robot is the first listed.

NCT05825508 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05825508 about?

NCT05825508 is a clinical study titled "PedBot Ankle Rehablitation". The primary objective of the study is to determine engagement with use and adherence to a home exercise program with our PedBotHome ankle rehabilitation device. We will place the device in the home for 90 days and consider the study a success if used for at least 30 minutes a day for at least 3 days...

What is the current status of trial NCT05825508?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2022-07-28. Estimated completion is 2025-07-28.

What conditions does trial NCT05825508 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT05825508?

The interventions under investigation include: ankle robot (DEVICE).

Who is sponsoring clinical trial NCT05825508?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05825508 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05825508's enrollment target sits among peer trials

20 67th of 91 higher than 19 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05825508, the US trial registry maintained by the National Library of Medicine. NCT05825508 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.